FR2882263B1 - Utilisation d'un derive du pyrazole pour la preparation de medicaments utiles dans la prevention et le traitement des maladies renales - Google Patents

Utilisation d'un derive du pyrazole pour la preparation de medicaments utiles dans la prevention et le traitement des maladies renales

Info

Publication number
FR2882263B1
FR2882263B1 FR0504798A FR0504798A FR2882263B1 FR 2882263 B1 FR2882263 B1 FR 2882263B1 FR 0504798 A FR0504798 A FR 0504798A FR 0504798 A FR0504798 A FR 0504798A FR 2882263 B1 FR2882263 B1 FR 2882263B1
Authority
FR
France
Prior art keywords
prevention
preparation
treatment
renal diseases
pyrazole derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0504798A
Other languages
English (en)
Other versions
FR2882263A1 (fr
Inventor
Mohammed Bensaid
Jean Marc Herbert
Philip Janiak
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Sanofi Aventis France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0501919A external-priority patent/FR2882262B1/fr
Application filed by Sanofi Aventis France filed Critical Sanofi Aventis France
Priority to FR0504798A priority Critical patent/FR2882263B1/fr
Priority to AU2006217794A priority patent/AU2006217794A1/en
Priority to BRPI0607894-0A priority patent/BRPI0607894A2/pt
Priority to MX2007009995A priority patent/MX2007009995A/es
Priority to EA200701800A priority patent/EA011655B1/ru
Priority to JP2007556630A priority patent/JP2008531526A/ja
Priority to KR1020077019170A priority patent/KR20070104916A/ko
Priority to CA002597802A priority patent/CA2597802A1/fr
Priority to PCT/FR2006/000369 priority patent/WO2006090047A1/fr
Priority to EP06709339A priority patent/EP1855675A1/fr
Priority to ARP060100612A priority patent/AR054003A1/es
Priority to TW095105981A priority patent/TW200640458A/zh
Publication of FR2882263A1 publication Critical patent/FR2882263A1/fr
Publication of FR2882263B1 publication Critical patent/FR2882263B1/fr
Application granted granted Critical
Priority to CR9270A priority patent/CR9270A/es
Priority to TNP2007000291A priority patent/TNSN07291A1/en
Priority to US11/832,861 priority patent/US7622488B2/en
Priority to IL185165A priority patent/IL185165A0/en
Priority to MA30159A priority patent/MA29263B1/fr
Priority to NO20074768A priority patent/NO20074768L/no
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR0504798A 2005-02-23 2005-05-12 Utilisation d'un derive du pyrazole pour la preparation de medicaments utiles dans la prevention et le traitement des maladies renales Expired - Fee Related FR2882263B1 (fr)

Priority Applications (18)

Application Number Priority Date Filing Date Title
FR0504798A FR2882263B1 (fr) 2005-02-23 2005-05-12 Utilisation d'un derive du pyrazole pour la preparation de medicaments utiles dans la prevention et le traitement des maladies renales
AU2006217794A AU2006217794A1 (en) 2005-02-23 2006-02-17 Use of a pyrazole derivative for preparing medicines useful for preventing or treating renal diseases
BRPI0607894-0A BRPI0607894A2 (pt) 2005-02-23 2006-02-17 utilização de um derivado de pirazol para a preparação de medicamentos úteis na prevenção e no tratamento das doenças renais
MX2007009995A MX2007009995A (es) 2005-02-23 2006-02-17 Utilizacion de un derivado de pirazol para la preparacion de medicamentos utiles en la prevencion y el tratamiento de las enfermedades renales.
EA200701800A EA011655B1 (ru) 2005-02-23 2006-02-17 Применение производного пиразола для получения лекарственных средств, подходящих для профилактики и лечения заболеваний почек
JP2007556630A JP2008531526A (ja) 2005-02-23 2006-02-17 腎臓病の予防または治療に有用な薬物を調製するためのピラゾール誘導体の使用
KR1020077019170A KR20070104916A (ko) 2005-02-23 2006-02-17 신장병의 예방 또는 치료에 유용한 의약의 제조를 위한피라졸 유도체의 용도
CA002597802A CA2597802A1 (fr) 2005-02-23 2006-02-17 Utilisation d'un derive du pyrazole pour la preparation de medicaments utiles dans la prevention et le traitement des maladies renales
PCT/FR2006/000369 WO2006090047A1 (fr) 2005-02-23 2006-02-17 Utilisation d'un derive du pyrazole pour la preparation de medicaments utiles dans la prevention et le traitement des maladies renales
EP06709339A EP1855675A1 (fr) 2005-02-23 2006-02-17 Utilisation d'un derive du pyrazole pour la preparation de medicaments utiles dans la prevention et le traitement des maladies renales
ARP060100612A AR054003A1 (es) 2005-02-23 2006-02-21 Utilizacion de un derivado de pirazol para la preparacion de medicamentos utiles en la prevencion y el tratamiento de las enfermedades renales
TW095105981A TW200640458A (en) 2005-02-23 2006-02-22 Use of a pyrazole derivative for preparing medicinal products that are of use in the prevention and treatment of kidney diseases
CR9270A CR9270A (es) 2005-02-23 2007-07-20 Utilizacion de un derivado de pirazol para la preparacion de medicamentos utiles en la prevencion y el tratamiento de enfermedades renales
TNP2007000291A TNSN07291A1 (en) 2005-02-23 2007-07-24 Use of a pyrazole derivative for preparing medicines useful for preventing or treating renal diseases
US11/832,861 US7622488B2 (en) 2005-02-23 2007-08-02 Use of a pyrazole derivative for preparing medicines useful for treating renal diseases
IL185165A IL185165A0 (en) 2005-02-23 2007-08-09 Use of a pyrazole derivative for preparing medicines useful for preventing or treating renal diseases
MA30159A MA29263B1 (fr) 2005-02-23 2007-08-23 Utilisation d'un derive du pyrazole pour la preparation de medicaments utiles dans la prevention et le traitement des maladies renales
NO20074768A NO20074768L (no) 2005-02-23 2007-09-18 Anvendelse av pyrazolderivater for fremstilling av medisiner nyttige for a forebygge eller behandle nyresykdommer

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0501919A FR2882262B1 (fr) 2005-02-23 2005-02-23 Utilisation d'un derive du pyrazole pour la preparation de medicaments utiles dans la prevention et le traitement des maladies renales
FR0504798A FR2882263B1 (fr) 2005-02-23 2005-05-12 Utilisation d'un derive du pyrazole pour la preparation de medicaments utiles dans la prevention et le traitement des maladies renales

Publications (2)

Publication Number Publication Date
FR2882263A1 FR2882263A1 (fr) 2006-08-25
FR2882263B1 true FR2882263B1 (fr) 2007-04-06

Family

ID=36603585

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0504798A Expired - Fee Related FR2882263B1 (fr) 2005-02-23 2005-05-12 Utilisation d'un derive du pyrazole pour la preparation de medicaments utiles dans la prevention et le traitement des maladies renales

Country Status (18)

Country Link
US (1) US7622488B2 (fr)
EP (1) EP1855675A1 (fr)
JP (1) JP2008531526A (fr)
KR (1) KR20070104916A (fr)
AR (1) AR054003A1 (fr)
AU (1) AU2006217794A1 (fr)
BR (1) BRPI0607894A2 (fr)
CA (1) CA2597802A1 (fr)
CR (1) CR9270A (fr)
EA (1) EA011655B1 (fr)
FR (1) FR2882263B1 (fr)
IL (1) IL185165A0 (fr)
MA (1) MA29263B1 (fr)
MX (1) MX2007009995A (fr)
NO (1) NO20074768L (fr)
TN (1) TNSN07291A1 (fr)
TW (1) TW200640458A (fr)
WO (1) WO2006090047A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010079241A1 (fr) 2009-01-12 2010-07-15 Fundacion Hospital Nacional De Paraplejicos Para La Investigacion Y La Integracion Utilisation d'antagonistes et/ou d'agonistes inverses des récepteurs cb1 pour la préparation de médicaments qui augmentent l'excitabilité des motoneurones
FR2958850B1 (fr) * 2010-04-14 2012-07-06 Centre Nat Rech Scient Medicaments pour la prevention ou le traitement des addictions aux drogues

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2692575B1 (fr) * 1992-06-23 1995-06-30 Sanofi Elf Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
FR2713225B1 (fr) * 1993-12-02 1996-03-01 Sanofi Sa N-pipéridino-3-pyrazolecarboxamide substitué.
FR2789079B3 (fr) 1999-02-01 2001-03-02 Sanofi Synthelabo Derive d'acide pyrazolecarboxylique, sa preparation, les compositions pharmaceutiques en contenant
US20040122033A1 (en) * 2002-12-10 2004-06-24 Nargund Ravi P. Combination therapy for the treatment of obesity
US20040214804A1 (en) * 2003-04-25 2004-10-28 Pharmacia Corporation Combination of an aldosterone receptor antagonist and an anti-obesity agent
AR051446A1 (es) * 2004-09-23 2007-01-17 Bristol Myers Squibb Co Glucosidos de c-arilo como inhibidores selectivos de transportadores de glucosa (sglt2)

Also Published As

Publication number Publication date
NO20074768L (no) 2007-11-23
CR9270A (es) 2007-10-01
MA29263B1 (fr) 2008-02-01
EA200701800A1 (ru) 2008-02-28
TNSN07291A1 (en) 2008-12-31
KR20070104916A (ko) 2007-10-29
TW200640458A (en) 2006-12-01
WO2006090047A1 (fr) 2006-08-31
US20080015228A1 (en) 2008-01-17
IL185165A0 (en) 2008-06-05
EA011655B1 (ru) 2009-04-28
FR2882263A1 (fr) 2006-08-25
BRPI0607894A2 (pt) 2009-10-20
MX2007009995A (es) 2007-10-10
AU2006217794A1 (en) 2006-08-31
EP1855675A1 (fr) 2007-11-21
JP2008531526A (ja) 2008-08-14
CA2597802A1 (fr) 2006-08-31
AR054003A1 (es) 2007-05-30
US7622488B2 (en) 2009-11-24

Similar Documents

Publication Publication Date Title
FR20C1048I2 (fr) Utilisation du désoxycholate de sodium pour l' élimination non chirurgicale de graisse
FR2869541B1 (fr) Utilisation d'une composition comprenant du d-mannoheptulose et/ou du perseitol dans le traitement et la prevention des maladies liees a une modification de l'immunite innee
MA28689B1 (fr) Derives de pyrrozolotriazine utiles pour le traitement des troubles et maladies hyperproliferatifs associes a l'angiogenese
FR2867778B1 (fr) Utilisation de derives d'indazolecarboxamides pour la preparation d'un medicament destine au traitement et a la prevention du paludisme
FR15C0046I2 (fr) Medicaments pour le traitement ou la prevention de maladies fibrotiques
FR13C0060I2 (fr) Omega-carboxyaryldiphenyluree fluoro-subtituee pour le traitement et la prevention de maladies et d'etats pathologiques
HK1076737A1 (en) Use of ep4 receptor ligands in the manufacture of a medicament for the treatment of il-6 involved diseases ep4
GB0412753D0 (en) Pharmaceutical compositions for the treatment of disease and/or symptoms in arthritis
FR2854074B1 (fr) Utilisation de l'ivermectine pour le traitement de desordres dermatologiques
IL190284A (en) Use of milenzipran, or a suitable pharmaceutical salt, in the preparation of a drug for the treatment of fibromyalgia
IL189500A (en) 4, 2-Diaminopyrimidines are preserved in position 5, containing pharmaceutical preparations and using them to prepare a drug for the treatment of 3x2p receptor mediated diseases and 2/3 x2p
MA29084B1 (fr) Derives d'indenyle et leur utilisation dans le traitement de troubles neurologiques
FR2882654B1 (fr) Utilisation de derives de la diosmetine pour le traitement et la prevention des pathologies thrombotiques
FR2883182B1 (fr) Composition de vitamines utiles dans le traitement des maladies oculaires
IL191289A (en) Pharmaceuticals containing metitrone and benzodiazepine and their use in the preparation of a drug for the treatment of neuropsychiatric disorders
FR2882263B1 (fr) Utilisation d'un derive du pyrazole pour la preparation de medicaments utiles dans la prevention et le traitement des maladies renales
FR2882262B1 (fr) Utilisation d'un derive du pyrazole pour la preparation de medicaments utiles dans la prevention et le traitement des maladies renales
FR2882261B1 (fr) Utilisation d'un derive du pyrazole pour la preparation de medicaments utiles dans la prevention et le traitement du diabete du type 2
FR2906469B1 (fr) Utilisation de composes de la famille des avermectines pour le traitement de desordres dermatologiques chez l'homme
FR2861300B1 (fr) Utilisation d'un derive du pyrazole, pour la preparation de medicaments utiles dans la prevention et le traitement du syndrome metabolique
FR2861301B1 (fr) Utilisation du derive du pyrazole pour la preparation de medicaments utiles dans la prevention et le traitement du syndrome metabolique.
FR2869539B1 (fr) Compositions pharmaceutiques pour la prevention et le traitement de l'atherosclerose
FR2892722B1 (fr) Composes de type methanone et leur utilisation dans des compositions pharmaceutiques notamment pour le traitement des maladies cardiovasculaires
FR2882265B1 (fr) Utilisation d'un derive du pyrazole pour la preparation de medicaments utiles dans la prevention et le traitement du diabete du type 2.
FR2867685B1 (fr) Utilisation d'un derive du pyrazole, pour la preparation de medicaments utiles dans la prevention et le traitement de la bronchite chronique et de la broncho-pneumopathie chronique obstructive

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20110131